Can Prevention Start in the Immune System?
If cancer risk is shaped by both genes and environment, can we strengthen the body’s frontline defenses? In this conversation, we explore how natural killer (NK) cell–derived exosomes may one day support prevention strategies—especially for people with higher-than-average risk due to genetics, occupational exposures, or past diagnoses. While clinical marketing claims are not FDA-approved, early research outside the U.S. and limited U.S. access have sparked careful, physician-guided experimentation.
What We’re Seeing in Early Practice and Research
Reports from Europe and Asia describe exosome use both intravenously (for circulating tumor cells) and locally (injected into solid tumors). The aim: selectively pressure abnormal cells while minimizing collateral damage to healthy tissue. In practice groups like Dr. Gross’s, access remains limited by supply and cost; when available, clinicians are exploring how exosomes might complement standard care—not replace it.
Integrative Oncology: Adjuncts, Not Either/Or
A number of integrative protocols—high-dose IV vitamin C, dietary phytonutrients (e.g., berries and other plant compounds), and occasionally repurposed medicines under medical supervision—are discussed in functional oncology circles. The central theme isn’t “ditch standard care”; it’s informed choice: when appropriate, combine conventional therapies with evidence-aware adjuncts to improve resilience, reduce inflammation, and support quality of life.
Why Access Is Hard: Supply, Scale, and Precision
NK cells make up a small fraction of immune cells, and producing NK-derived exosomes is labor-intensive lab work. Limited supply drives cost and makes protocols inconsistent across clinics. Access will likely improve as labs scale and as precision delivery advances—think robotic, 3D-guided injections for targeting solid tumors while minimizing exposure to the rest of the body.
Beyond Oncology: Joint Pain, Recovery, and Inflammation
Outside cancer care, clinics report using stem cell–derived exosomes (and sometimes NK-derived formulations where available) for osteoarthritis, spine pain, post-viral syndromes, and recovery after cardiac or neurologic events. Some patients describe better energy, improved training recovery, and reduced aches following carefully dosed IV infusions or image-guided joint injections—again, as part of broader, individualized plans.
Longevity Lens: Clearing “Zombie Cells” and Rebooting Resilience
Aging biology features senescent (“zombie”) cells—metabolically active but dysfunctional cells that leak inflammatory signals. NK-derived exosomes are being studied for their potential to help clear senescent cells and re-energize immune function. Some clinics pair exosome protocols with hormone optimization (when appropriate), resistance training, protein adequacy from whole foods, and hormetic stressors like sauna, cold exposure, or time-restricted eating—an approach that treats longevity as a systems problem, not a single intervention.
What a Personalized “Biohacker” Plan Can Look Like
A typical plan begins with deep assessment: sleep, stress load, movement, nutrition, supplements, lab panels (including inflammatory markers), and sometimes biological age metrics. From there, clinicians may recommend targeted nutrition, circadian alignment, structured training, and—only if indicated—PRP, stem cell–derived exosomes, or NK-derived exosomes. Because supply is tight and dosing varies, costs can range from the low four figures for lab workups to mid-four figures for infusion sessions; schedules depend on response, goals, and budget.
Guardrails: Safety, Claims, and Informed Consent
In the U.S., marketing claims for exosomes are not FDA-approved, which limits advertising and requires careful patient education. Ethical practice means: transparent risks and uncertainties, realistic expectations, and collaboration with oncology and primary teams. Patients should understand costs, dosing rationales, evidence strength, and alternatives—including the option to do nothing.
Practical Takeaways
- Think “both/and,” not “either/or.” When appropriate, pair standard care with evidence-aware adjuncts under medical supervision.
- Address the epigenetic basics first: anti-inflammatory eating patterns, sleep regularity, strength training, stress skills, and joyful movement.
- If exploring exosomes, ask about source, dosing, imaging guidance, goals, metrics, and cost—and loop in your care team.
- Remember that access and evidence are evolving; stay curious, cautious, and collaborative.
Listen to this conversation: the ANEW Insight Podcast episode with Dr. Jeff Gross (Part 2) on our podcast page.
Ready to apply the daily practices that lower inflammatory load? Start the Deprogram Diet Culture course.
Prefer a guided read? Get the Deprogram Diet Culture book.
Here is the Full transcript:
Dr. Supatra Tovar: [00:00:00] Welcome back to the ANEW Insight podcast. We are back for the second half of our interview with board certified neurosurgeon and visionary founder of ReCELLebrate Dr. Jeff Gross. Jeff gave us some invaluable insight into his inspiration to found ReCELLebrate. I am so excited to learn more. This is excellent stuff.
Dr. Supatra Tovar: Welcome back Dr. Jeff.
Dr. Jeff Gross: Thank you so much.
Dr. Supatra Tovar: In terms of prevention, could natural killer exosome therapy be a viable option for individuals with genetic predispositions or other high risk profiles?
Dr. Jeff Gross: I mean, yes. One, one of the applications theoretically would be to take people who are at high genetic risk or even high epigenetic risk like , they’ve been exposed to things that they shouldn’t have been, and maybe they worked in a coal mine and they’ve got, [00:01:00] potential for cancer that’s higher than the, than the average bear.
Dr. Jeff Gross: Then we could use this perhaps as a suppression or a preventative tool, at least theoretically. I would agree with that.
Dr. Supatra Tovar: Wow. And has it been used for high profile cancer cases?
Dr. Jeff Gross: Not
Dr. Supatra Tovar: To your knowledge?
Dr. Jeff Gross: Not yet, but that’s one of the groundbreaking things we’re working on here, where we wanna offer that to people who are at high risk and want to stay in remission.
Dr. Supatra Tovar: Yes. Well give us a, a picture of the current research as far as who it’s been used on, how effective it’s been. Maybe give us a, a few success stories.
Dr. Jeff Gross: Yeah, I mean, amazing research again, mostly out of Europe and China as we discussed in our first half. But these, these are people with circulating tumor cells. So sometimes those are bloodborne cancers like leukemia, things like that have had wonderful results there. Also with solid tumors, injecting solid tumors, liver, breasts, or even some brain tumors that have [00:02:00] been. Having amazing results, again, without chemotherapy, without radiation therapy, without known side effects showing, just these solid tumors shrinking. And I mean, that’s why we wanted to get our hands on these. We think this is a tool we should offer to people. I mean, one of, one of my jobs is not only to relieve suffering and help people with pain, but you know, protect their rights to access to things that are difficult to get so. Since there are no known harm of this type of thing and the results are good and there’s medical evidence to back it up, we want to do that for people.
Dr. Supatra Tovar: Absolutely. Is there anyone else in the United States who is doing this kind of work, or are you the pioneer?
Dr. Jeff Gross: Well, there are some others. In my we, I’m part of a group called the therapeutic regenerative exosome group. and we we talk about things like this, and my colleagues will be using this by using these types of things. So I’ve, I’ve, shared the labs where we can get them. There are very limited doses.
Dr. Jeff Gross: When I obtained the first 10 [00:03:00] doses of the NK exosomes, there were 40 available from, from that source.
Dr. Supatra Tovar: Right.
Dr. Jeff Gross: I basically got, 25% of what Europe had at the moment. So, my, my colleagues are offering this and going to be offering this, some of them. And I’ve talked to functional and integrative oncologists who are using different methods
Dr. Jeff Gross: to approach cancer. Ivermectin fenbendazole, mebendazole other, repurposed pharmaceuticals or antiparasitic medications. High dose IV vitamin C, which is known to be suppressive, fasting use of, of berries, if you, this is crazy, but there are wonderful protocols. For utilizing like berries or freeze dried berries, which you can get from Trader Joe’s to help suppress cancer. The phytonutrients are incredibly active
Dr. Supatra Tovar: Yes.
Dr. Jeff Gross: in that way. And you can find this on PubMed, which is where we go to look for some medical research, but you won’t hear about it from your oncologist who will offer you chemotherapy.
Dr. Jeff Gross: Now, I’m not saying ignore [00:04:00] chemotherapy, it’s wrong. I’m not saying that. But you should know about all options and you might. Combine some options. You might use some traditional and some of these natural and cutting edge therapies as well.
Dr. Supatra Tovar: Yes, you made me shiver a little talking about Ivermectin. I’m like, oh, no. But how is it used in, in the correct way?
Dr. Jeff Gross: Well, I mean, we are seeing, and studies are arising that ivermectin combined with either mebendazole or fenbendazole, which are anti antibiotics, anti-parasitics, can have a cancer reducing effect. There, there’s some discussion of where the dose is or how to use it, and a lot of people who are interested in alternative protocols for cancer or augmentative protocols adding to a traditional approach that they can have these things. They have little downside, and we have had ivermectin around and animals get it, and I see people online that are [00:05:00] buying it from, tractor supply because
Dr. Supatra Tovar: Yes.
Dr. Jeff Gross: for horses and, and, and they’re just taking a daily oral dose. It’s, I guess it comes in a paste or something.
Dr. Supatra Tovar: Hmm.
Dr. Jeff Gross: But we, you can get the pills. You can, you can have access to this and. And why not?
Dr. Supatra Tovar: Yeah, absolutely. But best under the care of your doctor, I would assume. And gimme a picture too. It’s, it’s, it’s promising to hear about high dose intravenous vitamin C that I thought was kind of poo-pooed for a while, but,
Dr. Jeff Gross: It is a no brainer. It’s vitamin C and it’s highly antioxidative. It helps repair. So it it, it’s cancer suppressing. Again, go to PubMed, type it in. There are protocols that go back decades.
Dr. Supatra Tovar: Yes. I think it’s so exciting to hear about this. Gimme a, a picture too of the primary barriers to widespread access to NK cell derived exosomes. [00:06:00] And how have you been able to overcome them at ReCELLebrate?
Dr. Jeff Gross: I, I just made the right connections, is how I overcame it. But, but and I was persistent,
Dr. Supatra Tovar: Wow.
Dr. Jeff Gross: Just like I am with, with my patients. We wanna help them get better, but I, I think that the first, the first part is, as I noted, NK cells are only a very small percent of the immune system.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: when these are harvested from, amniotic fluid or umbilical cord cells, it’s a very, very small percentage.
Dr. Jeff Gross: You have to go through a lot of cells to find a few NK cells, and then they have to go into the right, cell culture, petri dish type situation and produce enough exosomes. It’s laborious. I mean, it’s very, gonna call it factory intensive. A lab intensive. So, and then you have to accumulate it over time.
Dr. Jeff Gross: So the labs that produce ’em are getting better at that. And it’s just, it’s, it is a very difficult process, so it’s not something you could just do.
Dr. Supatra Tovar: Wow. So what needs to happen to make [00:07:00] this treatment more accessible to most people?
Dr. Jeff Gross: I think that as the labs have found more efficient ways to collect and harvest these, these exosomes from the NK cells and also
Dr. Jeff Gross: Hmm.
Dr. Supatra Tovar: collecting
Dr. Jeff Gross: the NK cells, we will have more access to them. As the protocols become more refined, know, how to inject. For example, we are in the process of, of putting together a state-of-the-art robotic 3D guided injection center so we can inject solid tumors anywhere in the body.
Dr. Supatra Tovar: Wow.
Dr. Jeff Gross: Probably not gonna be doing the brain right away, but the rest of the body. Yes. So we can be precise in how we deliver it so you don’t have to poison the whole body necessarily with chemotherapy to take out a tumor which would be great. Right? This is more what we call precision medicine or targeted medicine.
Dr. Supatra Tovar: Yes. Can we do that for dogs too? I just had to see my dog through radiation and chemotherapy, and luckily he’s fine, but I can assume that maybe that will [00:08:00] be available for vets as well someday.
Dr. Jeff Gross: Listen, the, a lot of the stem cell research came out of the thoroughbred horse cottage industry. Those folks who invest in these horses were, spared no expense. So, a lot of early stem cell work came out of those guys. And, and some of the first human adopters were horse owners, ranchers, and, and race horse owners.
Dr. Supatra Tovar: Oh, I love that. Well, I, I do work through the Healing Equine Ranch, so my partner Kiki will be very happy to hear that her horses are so precious to her. Gimme a, a case study or a patient story where this therapy led to significant improvement or even remission.
Dr. Jeff Gross: Well, we’re just in the beginning of that on my end, so I don’t have my own stories. We are using these in clinical practice now.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: Most of my, my success stories have come from using. Regular stem cell derived exosomes. We treat, many other things all the way from joint degeneration, helping people avoid [00:09:00] knee replacement surgery
Dr. Jeff Gross: for example, spine issues , hyper inflamed states, autoimmune. I. Problems, long covid, lymes, things like that
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: Recovering from heart attack, stroke, and even preventative. We have biohackers and preventative longevity seekers that come in for routine. I’m one of them. My wife and I do this.
Dr. Jeff Gross: My mother comes in for exosomes, my stepfather, many people and they’re in their eighties and they, they have four to six months boost in energy. And it’s like that movie Cocoon. They, they, they, they got a little dose of youth. So that’s what.
Dr. Supatra Tovar: I love that movie so much. Well, let’s delve into longevity. Give me a picture. You just kind of gave me a little bit of an overview, but go into that a little bit more. How do these exosomes support immune rejuvenation and what role do they play in anti-aging medicine?
Dr. Jeff Gross: Well, we talked about stem cells and of course, stem cell, ex derived [00:10:00] exosomes being immunomodulatory.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: the immune system, so if you need a, if you need a boost to your immune system. These will help activate and awaken the stem cells in your immune system to, to put out, if you
Dr. Supatra Tovar: will.
Dr. Supatra Tovar: Mm.
Dr. Jeff Gross: So, we, we’ve seen this time and time again.
Dr. Jeff Gross: And and we know that because the majority of our stem cells, not all, but the majority live in our bone marrow, where those hematopoietic cells are doing their job to make red blood cells, to make white blood cells to stimulate the immune system. ’cause the immune system gets cranky and bogged down and cobwebs from all the inflammation, just like all of our other cells.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: We need that. We’re also seeing, interestingly, supporting your bone. I, I said earlier, supporting your bone density and your muscle mass are correlated with longevity to, so supporting your bone density is because you’re supporting your own stem cell system, right? So if you have osteoporosis, your bones are being bleached out and you, your bone marrow is converting into fat, Or red, to yellow bone marrow conversion and that. [00:11:00] That means you have fewer stem cells. So we do have improvement in, in, when, when we infuse stem cell derived exosomes into people, we have improvement sometimes in their bone density.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: have, one of the early uses of the exosomes actually was to he a fracture. Or to a hip that has undergone what’s called avascular necrosis or osteonecrosis.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: Those, those hips usually need replacement. But this was well demonstrated by the French about 20 years ago, that you can inject these biologics into the bone of the hip and reanimate the cells and the life of the bone marrow within the hip.
Dr. Jeff Gross: So that’s all we’re doing. It’s, it’s kind of too easy, if I can say.
Dr. Supatra Tovar: That’s incredible, but you don’t hear about it at all. You hear, if somebody breaks their hip, they have to have a hip replacement. They’ve got something going on with their knee, they need surgery. Is it the same kind of forces at work [00:12:00] against these therapies from industries that don’t want this stuff out there?
Dr. Jeff Gross: Maybe it’s just not mainstream. They’re not teaching this in med schools,
Dr. Supatra Tovar: Hmm.
Dr. Jeff Gross: What you learn from your professors is what they learn 20 years earlier and what their professors learn 20 years earlier, and things are just not moving fast enough in, in that field, so you’re not gonna get that option if you go see someone who hasn’t, opened their mind to it.
Dr. Supatra Tovar: Okay.
Dr. Jeff Gross: And if you had asked me, seven, eight years ago, before I made the switch, hey I’ve got spine pain, will you, is there a stem cell option? My answer was, I don’t know. I really haven’t studied that. Right. Some doctors are flat out, no, it’s not proven, it’s illegal.
Dr. Jeff Gross: They, these myths come up and really what they need to do is open a different book and do a little
Dr. Supatra Tovar: Mm,
Dr. Jeff Gross: updated reading.
Dr. Supatra Tovar: yes. Does it help with things like arthritis as well?
Dr. Jeff Gross: That’s the number one thing we address at my practice is osteoarthritis, which is degeneration of joints. We take people who are bone on bone who are looking at knee replacement or some kind of joint replacement and we try [00:13:00] to help them not need that anymore, put it off. There’s always gonna be some role for surgery.
Dr. Jeff Gross: But if we can diminish the hundreds of thousands of joint replacements done every year, I think we’re, we’re helping ’cause those are big surgeries with lots of recovery and downtime and pain, a simple injection of stem cell derived exosomes. Why not try it,
Dr. Supatra Tovar: Oh my gosh, yes. Maybe it’ll help my, I have a little tiny arthritis in the back of my neck here, so I might be coming to you. You’re in California, right?
Dr. Jeff Gross: No, we closed the California location and we’re only here in the Las Vegas area now. Sorry, everybody. But California’s a beautiful place. They just have some issues that need to work out before I come back.
Dr. Supatra Tovar: Oh, gotcha. I, I hear you. Okay, well now walk me through a typical if there is one biohacker and, and what they are wanting to do and how, what does the procedure look like? And if you if you are, feel comfortable enough, if you telling us what it might cost, [00:14:00] the biohacker walk us through their, their treatment.
Dr. Jeff Gross: Yeah. So, we deconstruct everyone individually. So, you know what we, like I said, we go through all the epigenetic things. Let’s, let’s look at your sleep, your diet, your supplements, your nutrition, your, exercise, your regimen, your supplements. We might do some lab tests. Some people already have them.
Dr. Jeff Gross: We might do an age a biological age test.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: We might look deeper in inflammatory markers. Stuff your regular Dr. May not order ’cause it’s atypical, specialty
Dr. Supatra Tovar: mm-hmm.
Dr. Jeff Gross: items, right, that we look at and we tweak all that. Sometimes we’re talking about bioidentical hormone optimization, both men and women. The, the school of thought on that is if you can maintain your usual youthful hormone profile you are fighting against inflammation and you’re fighting against aging, and you won’t you’ll, you’ll slow down the age related changes and et cetera.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: We look at all of that and then, and only then if there’s still issues we want to deal with and might just be [00:15:00] preventative, then we look at the regenerative side of things and we have access to stem cells, we have access to PRP, we have access to exosomes.
Dr. Jeff Gross: PRP is very low power. It can help and, and we realize that, but we’ve really focused on the stem cell and exosome side of things. We have found, at least in my practice, exosomes are no less useful than stem cells, but they’re about a third of the cost. So
Dr. Supatra Tovar: Wow.
Dr. Supatra Tovar: all things
Dr. Jeff Gross: created equal. I’m a stem cell derived exosome fan for my preventative and anti-inflammatory crowd.
Dr. Supatra Tovar: Mm-hmm. So. What would that cost the typical biohacker say that they wanna come in, they wanna get that full lab workup? They want, all of the recommendations that you have to give about diet, lifestyle, exercise, and then they want exosome treatment.
Dr. Jeff Gross: They’re
Dr. Supatra Tovar: Is it covered by insurance?
Dr. Jeff Gross: Not generally unless they have a health savings account or a flexible spending account where they get to control the health [00:16:00] dollars.
Dr. Supatra Tovar: Hmm.
Dr. Jeff Gross: But you can deduct as a tax deductible expense above a certain percentage of your adjusted gross. I’m not a tax professional. I sound like I might be one, but I’ve heard this before.
Dr. Supatra Tovar: Yeah, that was just like,
Dr. Jeff Gross: You can deduct some a certain amount. There’s a, there’s an exclusion at the bottom end. Certain percentage of your A GI, it used to be 3%. I think it’s seven and a half or something now. I don’t know,
Dr. Supatra Tovar: mm-hmm.
Dr. Jeff Gross: but, so you can at least deduct it. So you can at least get In California, that means you get half your money back back or more.
Dr. Supatra Tovar: Wow. That’s great.
Dr. Jeff Gross: yeah.
Dr. Jeff Gross: So in, in at least off your taxes, in terms of the, the health savings and the flexible spending account’s, a great way to use that, those funds.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: But the, workup with all the fancy labs and tests might be a thousand dollars ish. And then the IV exosomes, let’s say you did one, you wanna try one treatment depends on the dose we use.
Dr. Jeff Gross: So, a starting dose might be five ccs, which is about 1.3 [00:17:00] trillion exosome particles by count. Plus it has growth factors and. All the goodness of PRP and amniotic fluid, which amniotic fluid’s magic, right? I mean, if
Dr. Supatra Tovar: you’ve
Dr. Jeff Gross: Hmm.
Dr. Jeff Gross: ever, take a little aside here. If you ever take a fetus and operate on it, and we used to do that in neurosurgery, right?
Dr. Jeff Gross: We, we’d identify by ultrasound, something called spina bifida where the spine was open
Dr. Supatra Tovar: Right.
Dr. Jeff Gross: it, there was research. If you went in through the uterus and closed that opening, the child would have a better outcome long term.
Dr. Supatra Tovar: Wow.
Dr. Jeff Gross: So we noticed though, when those children were later born, after having that in utero surgery, they’d come out with not no scar on their backs. So there’s something magic about amniotic fluid, and we’re tapping into that magic and being, trying to make it available to people. So, so if you went a five cc dose you’re, you’re looking at around, I don’t know, $6,000 give or take for that dose. It’s expensive. We have to buy these, from, from the labs that, that get ’em from the donors.
Dr. Jeff Gross: And [00:18:00] we’re, we’re down the chain in the, in the process. You, a 10 cc dose is not twice as much. It, it goes up a little less just because, it’s, it’s the economy of scale. When my mother and stepfather come in, they, they split 15 ccs,
Dr. Supatra Tovar: Mm.
Dr. Jeff Gross: it’s even, it’s affordable for them.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: That. That’s just kind of how we approach it. And some people do that once a year. They do it maybe every six months. Just depends on the person, how inflamed the person is and what benefits they felt. I have some young healthy people who don’t feel a whole lot ’cause they’re already super healthy, but their HRV goes up.
Dr. Jeff Gross: And for those listeners who don’t know what I’m talking about, that’s heart rate variability, which you can track on your Apple. Watch your Oura ring. Or your whoop band or some of the Garmin devices now, which is a very sensitive health metric about the variability between heartbeats.
Dr. Supatra Tovar: Mm-hmm. And so the exosome therapy improves that,
Dr. Jeff Gross: Yeah.
Dr. Supatra Tovar: and that’s, that’s how the younger people are [00:19:00] seeing it.
Dr. Jeff Gross: Yes.
Dr. Supatra Tovar: What, what about your own personal
Dr. Jeff Gross: Yeah, yeah,
Dr. Supatra Tovar: results? What have you, what have you seen it do for you?
Dr. Jeff Gross: I do it every few months. I, I, I’ve done two ccs, I’ve done 10 ccs. I I feel a boost in energy. I feel like I’m more motivated and cognitively I can, I do a lot of writing. I write textbook chapters on this topic. I write, journal, medical journal articles.
Dr. Jeff Gross: I write blogs and things I can write, and I’m, I can just, a lot more comes out of my brain clearly, I, I can, I can recover from workouts quicker, faster, without being achy. I little aches and pains I have accumulated in my 59 years have,
Dr. Supatra Tovar: No, you guys, he is 90. He’s just saying that.
Dr. Jeff Gross: yeah. It should be the I mean, those go away. I, I can put on more muscle right after, I’ve noticed that. So that’s important on my workouts, so get more out of that. Things like that. I just, I just feel good.
Dr. Supatra Tovar: Oh, this is so great. What about your wife? What does she, what does she notice?
Dr. Jeff Gross: she’ll tell you the [00:20:00] same she’s actually a, a poster child because she had knee issues going way back, old skiing injuries.
Dr. Jeff Gross: And so we injected her, her knees in a targeted way based on an MRI and everything. And she, we have before and after MRIs on her where we’ve seen the cartilage in her knees become thicker. So, she feels great. She can wear high heels down the, down the stairs again without having to go super slowly.
Dr. Jeff Gross: So, she’ll tell you,
Dr. Supatra Tovar: Oh my gosh, this is so promising.
Dr. Jeff Gross: yeah.
Dr. Supatra Tovar: and, and does she notice too, I mean, I think people who biohack wanna see more youthful appearance. Does she notice that in herself?
Dr. Jeff Gross: Well, she’s already amazingly beautiful, so I can, I, I, I wanna make sure she sees this podcast later, so I get the credit for that. But she she we’ve done micro injections. We have a few little aesthetic things we can do for her. We’ve done some scalp injections with the exosomes to stimulate some follicle regeneration for thinning hair.
Dr. Jeff Gross: So we’re, we’ve got [00:21:00] other things we do. We just, we’d have to have a third or fourth podcast to get into those. I.
Dr. Supatra Tovar: Oh my gosh. I, I think we might have to, because this is so interesting and I just, I’m so excited for the future. And, and give us a picture. How do you envision this therapy evolving? I mean, could it be a frontline treatment
Dr. Jeff Gross: Oh
Dr. Supatra Tovar: even regular or preventative care for others?
Dr. Jeff Gross: It is a frontline treatment. It’s, it’s available in the us. I’m not the only doctor that has access to stem cells and exosomes. We cannot advertise because the FDA has not approved the marketing claims. So you, it’s very difficult. You, you won’t find us on Google Ads or on Facebook ’cause they won not let us,
Dr. Supatra Tovar: Hmm.
Dr. Jeff Gross: We wanna be compliant.
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: The but you search it, search on the internet, you will find, in your city, type in. Regenerative medicine, you’re in Southern California so you’ll, there are, I have colleagues that practice this there as well and we all come at it maybe a little bit different and that’s okay. A [00:22:00] lot of doctors do anyway. I think one of the holdbacks here will be big pharma is starting to get their fingers in it because they wanna monetize it, so that’ll raise the price of it, sadly. And you, we see that already on the cancer side of things. There’s a, there’s another regenerative cancer treatment called CAR T-Cell which is like chimeric ac antigen rece receptor T-cell, which is a very laborious process.
Dr. Jeff Gross: You have to take cells out of the body and insert a gene a cancer gene, get that cell to look angry and, and foreign and put it back in the body and have the immune system, deal with it. Sadly, it looks like kinda like the Covid system, right? So we gonna be very careful there. But the, Big Pharma is, is driving, is driving that. They’re looking to monetize that. So I feel that for this to become approved for marketing claims, it’s gonna take a lot of money. And that money’s gotta come from Big Pharma and they’re, they’re gonna increase the price of what you’re seeing right now.
Dr. Supatra Tovar: Wow. Do you see people skirting [00:23:00] around that maybe by going over to Asia or to Europe at this point?
Dr. Jeff Gross: that’s what people did for, for many years, 20 years ago, professional athletes were leaving the country for this. And, and still a lot of people go to Mexico or, or Central America where there are plenty of places now to get these things. But you don’t have to. We have them right here in the US.
Dr. Jeff Gross: You just have to find the right. And, and I, and I think that, there are open-minded doctors willing to, put down the Kool-Aid and, try something new and better and safe. Now I’m not allowed to say that the FDA hasn’t approved that word safe, but my patients have not had problems.
Dr. Jeff Gross: I can say
Dr. Supatra Tovar: Mm-hmm.
Dr. Jeff Gross: The medical evidence, the published research has not shown any harmful side effects from these things yet.
Dr. Supatra Tovar: Wow, this is amazing. So we sadly are out of time, but we may have to have a third podcast ’cause I could, ask you a million questions moving forward. But how do people get ahold of you and how do they work with [00:24:00] you? They can just pop over to Vegas somehow. So give, give all your information.
Dr. Jeff Gross: People do that. Yeah. So our practice is now called ReCELLebrate because you’re celebrating the renewal of yourselves. And the spelling is R-E-C-E-L-L-E-B-R-A-T-E. And as far as I know, if you search that online, we’re the only people using that word. So, ’cause we kind of made it up. So, you can find us on social media, you can find us online, and there’s, there’s always a way to reach, opt in, reach out, send us your information.
Dr. Jeff Gross: We’d love to meet new people. And for your listeners, for the first 20 callers, I’d be happy to set aside a 30 minute conversation for anyone interested at no, no cost because they heard me on, they have to mention your name though.
Dr. Supatra Tovar: Oh, awesome. Okay. We will put that in the show notes. Everyone oh my gosh. You could get a free consult with Dr. Jeff, who’s amazing, and I tell you, you, you do look youthful, you do look healthy, you do look [00:25:00] fit. And I’m sure your wife is absolutely gorgeous and you guys are really optimizing longevity science to help you age
Dr. Supatra Tovar: with grace, and I think that that’s amazing. But beyond that, beyond aging, beyond biohacking, what I think you are doing right now is revolutionary for cancer treatment. And I really hope everybody listens to this and does their research and does their homework. And I think it’s just so promising that there’s something out there beyond chemo, beyond
Dr. Supatra Tovar: radiation beyond surgery and cutting out parts of yourself. I think we’re headed into the kind of new frontier for medicine and I’m so grateful. So thank you so much for coming on the podcast, Dr. Jeff.
Dr. Jeff Gross: Thank you for having me.
Dr. Supatra Tovar: You’re awesome. And thank you everyone for tuning into the ANEW Insight podcast. I am really looking forward to the next interview.
Dr. Supatra Tovar: Hopefully it’ll be as good as this one. Thank you and [00:26:00] stay tuned and we’ll see you next time.
Recent Comments